Mark T Bertolini bought $12M of OSCR
Chief Executive Officer at Oscar Health, Inc.. 1,000,000 shares at an average of $11.92, traded Apr 6, 2026, filed Apr 7, 2026.
Score components
- +25RoleCEO
- +25Trade size$11.9M at market
- +3Relative to holdingsHoldings up 11%
- +8Price context43% below the 52-week high
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +60.9%, 3m +139.9%, 6m +149.3%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001352552-26-000008, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Apr 3, 2026 | MOption exercise Class A Common Stock | +5,733,334 | - | - | 10,196,877 | Apr 7, 2026 |
| Apr 6, 2026 | FTax withholding Class A Common Stock10b5-1 | -1,000,001 | $11.92 | $12M | 9,196,876 | Apr 7, 2026 |
| Apr 6, 2026 | POpen-market purchase Class A Common Stock | +1,000,000 | $11.92 | $12M | 10,196,876 | Apr 7, 2026 |
| Apr 3, 2026 | MOption exercise Performance Restricted Stock Unitsderivative | -5,733,334 | $0.00 | $0 | 0 | Apr 7, 2026 |
Related signals
Other insiders at Oscar Health, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 22Weak | Oscar Health, Inc. | Vanessa Ames Wittman director | $806k 25,000 shares | -18% | |
| 15Weak | Oscar Health, Inc. | Victoria Baltrus Chief Accounting Officer | $30k 958 shares | -0% | |
| 41Moderate | Oscar Health, Inc. | Richard Scott Blackley Chief Financial Officer | $908k 28,869 shares | -3% | |
| 30Weak | Oscar Health, Inc. | Janet Liang President, Oscar Insurance | $326k 10,360 shares | -4% | |
| 24Weak | Oscar Health, Inc. | Adam McAnaney Chief Legal Officer | $286k 9,092 shares | -4% | |
| 35Weak | Oscar Health, Inc. | Mario Schlosser President of Technology & CTO | $988k 31,422 shares | -7% | |
| 60Notable | Oscar Health, Inc. | Mario Schlosser President of Technology & CTO | $23M 750,000 shares | -69% | |
| 59Moderate | Oscar Health, Inc. | Richard Scott Blackley Chief Financial Officer | $595k 18,750 shares | -25% | |
| 48Moderate | Oscar Health, Inc. | Mario Schlosser President of Technology & CTO | $1.5M 47,500 shares | -100% | |
| 43Moderate | Oscar Health, Inc. | Mark T Bertolini Chief Executive Officer | $36M 1,238,996 shares | -14% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.